Back to search
Hemodialysis Subjects With Secondary Hyperparathyroidism
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hemodialysis Subjects With Secondary Hyperparathyroidism trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hemodialysis Subjects With Secondary Hyperparathyroidism trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) on hemodialysis.
MT1013 is a first-in-class dual-target agonist.This study is being conducted to determine the mass balance and routes of excretion of total radioactivity after…
This is a multi-center, open, single-arm phase IIb clinical study comprising 2 parts, which Part A will enroll about 110 subjects, and Part B will enroll about…
The main objective of this study is to evaluate the safety, efficacy and pharmacokinetics of paricalcitol oral solution in pediatric participants of ages 0 to 9…
This is a multicenter, single-arm, long-term safety and tolerability trial. A total of 300 subjects with chronic kidney disease on hemodialysis are planned to b…